ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002

Article Spotlight Article

Nixon National Cancer Conference Kicks Off

December 8, 2021

Emerging Technologies: Company To Expand Program Studying Polymer Platinates

June 1, 2001

Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time

December 30, 2011

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

Guest Editorial: Gerard Silvestri calls for uniform guideline for CT screening for lung cancer

July 1, 2011